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The Angiomotin (Amot) family of adaptor proteins directly coordinates signaling events during 
cellular and neural differentiation and proliferation. A critical feature of all Amot proteins is a 
novel lipid binding domain, the Amot coiled-coil homology (ACCH) domain, which confers its 
association with membranes and affects membrane curvature and deformation. Specifically, this 
domain has the unique ability to selectively bind monophosphorylated phosphatidylinositols 
(PIs) and cholesterol. Furthermore, Amot family members bind core polarity proteins that control 
the organization of the apical domain of epithelial cells as well as Yap, a transcriptional co-
activator that appears to be the key regulator of cell growth. 
Amots have been shown to have a critical role in endothelial and epithelial cell migration, 
invasion, and tubule formation, and they are believed to regulate angiogenesis, which promotes 
tumor growth and metastasis. Amot overexpression and mutations have been linked to 
neuroepithelial tumors, such as glioblastomas, brain hemangioendotheliomas, neurofibromatosis, 
and many other cancers, such as breast cancer. The role of Amots in epithelial and endothelial 
cancer growth and metastasis have been linked to poor prognosis and unfavorable clinical 
outcomes. 
Understanding the structure-function relationship of the ACCH domain may provide pathways to 
modulate protein sorting and downstream signaling events inducing cellular differentiation, 
cancer cell proliferation, and cell migration. The goal of this project is to generate a solution 
structure of the Amot80/130 and AmotL2 (Mascot) ACCH domains using SAXS and WAXS 
data as well as various protein modeling software, thereby suggesting possible routes to 
modulate their activity associated with various tumors. Additionally, this structure will be 
compared against theoretical models to determine the statistical accuracy of the theoretical 
models. Furthermore, we hypothesize that generating these models will allow us to determine the 
structure of another analogue of A80/130, the Angiomotin-like 1 (JEAP) ACCH domain. 
